
3 Digital Services Provider, Enterprise IT Group and Healthcare Operations Specialist Stocks With a Strong Future Roadmap: Mphasis, HCL Technologies and Inventurus Knowledge Solutions
Mphasis, HCL Technologies and Inventurus Knowledge Solutions: ROE of 17.3% to 25.8% and FY22 to FY26 revenue CAGR of 7.5% to 42.2%. Prices as of 28 Oct 2026.
Updated: 29 Oct 2026 • 12:31 pm
Posted by:

Quick Answer
The three digital, enterprise IT and healthcare services to watch are Mphasis, HCL Technologies and Inventurus Knowledge Solutions. Their return on equity ranges from 17.3% to 25.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.5% to 42.2%. Inventurus Knowledge Solutions leads on both return on equity at 25.8% and revenue growth at 42.2% a year. Prices are based on the 28 October 2026 close, and this article is educational, not investment advice.
Digital, enterprise IT and healthcare services offer a focused view of a sector where demand keeps widening. Mphasis, HCL Technologies and Inventurus Knowledge Solutions cover a digital services provider, an enterprise IT group and a healthcare operations specialist.
This list covers three digital, enterprise IT and healthcare services with complete current figures: Mphasis, HCL Technologies and Inventurus Knowledge Solutions. Every figure comes from the latest reported financials and the 28 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Digital, Enterprise IT and Healthcare Services?
Digital, enterprise IT and healthcare services are listed technology companies that build applications, cloud and modernisation projects for banks and insurers, deliver software, infrastructure and engineering services and support United States healthcare providers with revenue cycle and technology services. Their earnings depend on client budgets, deal wins and currency.
Digital, Enterprise IT and Healthcare Services at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Mphasis | 2,518 | 47,695 | 25.0 | 17.5 | 17.3 | 0.24 |
| HCL Technologies | 1,400.5 | 384,255 | 21.0 | 17.6 | 24.1 | 0.08 |
| Inventurus Knowledge Solutions | 1,692.8 | 29,242 | 38.3 | 17.6 | 25.8 | 0.27 |
On valuation, all three trade at a P/E above their industry P/E, which reflects the growth the market already expects from them. Readers comparing digital, enterprise IT and healthcare services should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Digital, Enterprise IT and Healthcare Services Have a Strong Roadmap in India?
Digital, enterprise IT and healthcare services have a strong roadmap in India because steady global spending on digital transformation, cloud and data work and rising outsourcing in healthcare keep widening the market for Indian technology and services firms.
- Cloud projects. Banks and insurers modernise core systems.
- Infrastructure work. Large clients outsource technology operations.
- Healthcare services. Providers outsource billing and technology tasks.
Why Mphasis Features Among These Digital, Enterprise IT and Healthcare Services
Among the digital, enterprise IT and healthcare services on this list, Mphasis is a Bengaluru-based IT services company that provides applications, cloud, data and consulting services to clients in banking, insurance and technology, especially in the United States.
In the June 2026 quarter, revenue grew 17.1% year on year to Rs 4,467 crore, while net profit rose 10.8% to Rs 490 crore. Revenue rose from Rs 12,122 crore in FY22 to Rs 16,206 crore in FY26, a compound annual growth rate of 7.5%.
Net profit grew from Rs 1,431 crore in FY22 to Rs 1,863 crore in FY26, which works out to a compound annual growth rate of 6.8%. The company has a return on equity of 17.3%, a debt to equity ratio of 0.24 and a market capitalisation of Rs 47,695 crore. The stock trades at a P/E of 25.0, above the industry P/E of 17.5.
Roadmap: The company has stressed an AI-led approach and strengthened its sales relationships with large clients. A broad client base in financial services provides recurring revenue, and its investments in cloud and data skills support growth.
What to watch: Monitor deal wins and client spending trends in banking and financial services.
Why HCL Technologies Features Among These Digital, Enterprise IT and Healthcare Services
Among the mid cap IT and healthcare services shares on this list, HCL Technologies is a Noida-headquartered global technology company that provides software services, engineering and R&D services, infrastructure management and its own software products to large enterprises.
The company has a return on equity of 24.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 384,255 crore. The stock trades at a P/E of 21.0, above the industry P/E of 17.6.
Revenue rose from Rs 86,718 crore in FY22 to Rs 131,674 crore in FY26, a compound annual growth rate of 11.0%. Net profit grew from Rs 13,523 crore in FY22 to Rs 16,652 crore in FY26, which works out to a compound annual growth rate of 5.3%.
Roadmap: The company is building its business around cloud, data and artificial intelligence services and large multi-year deals with global clients. Its engineering services and software product lines add recurring revenue alongside core IT services.
What to watch: Monitor large deal wins, demand for artificial intelligence services and currency movements.
Why Inventurus Knowledge Solutions Features Among These Digital, Enterprise IT and Healthcare Services
Among the three companies on this list, Inventurus Knowledge Solutions, known as IKS, is a Mumbai-based healthcare technology and services company that supports healthcare providers and payors in the United States with analytics, clinical coding and technology platforms.
Revenue rose from Rs 784 crore in FY22 to Rs 3,211 crore in FY26, a compound annual growth rate of 42.2%. Net profit grew from Rs 233 crore in FY22 to Rs 722 crore in FY26, which works out to a compound annual growth rate of 32.7%.
In the June 2026 quarter, revenue grew 21.0% year on year to Rs 899 crore, while net profit rose 27.8% to Rs 194 crore. The company has a return on equity of 25.8%, a debt to equity ratio of 0.27 and a market capitalisation of Rs 29,242 crore. The stock trades at a P/E of 38.3, above the industry P/E of 17.6.
Roadmap: The company is widening its technology-led services for risk adjustment, care coordination and revenue cycle work. Long-term relationships with large healthcare organisations give it recurring demand.
What to watch: Follow client additions, platform adoption and healthcare policy changes in the United States.
Mphasis vs HCL Technologies vs Inventurus Knowledge Solutions on Key Financials
The table below sets the three digital, enterprise IT and healthcare services side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Mphasis | 12,122 | 16,206 | 7.5% | 1,863 | 11.5% |
| HCL Technologies | 86,718 | 131,674 | 11.0% | 16,652 | 12.6% |
| Inventurus Knowledge Solutions | 784 | 3,211 | 42.2% | 722 | 22.5% |
Inventurus Knowledge Solutions posts the highest return on equity in this group at 25.8%. HCL Technologies has the largest FY26 revenue at Rs 131,674 crore, and Inventurus Knowledge Solutions shows the fastest revenue growth with a 42.2% compound annual rate. A useful habit with digital, enterprise IT and healthcare services is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Digital, Enterprise IT and Healthcare Services
Every theme carries risks that deserve a check before any decision. For these digital, enterprise IT and healthcare services, the main points are: Long-term mid cap IT and healthcare services shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Deal timing. Large contracts can shift between periods.
- Client budgets. Spending can vary with global conditions.
- Currency moves. Export earnings move with the rupee.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter digital, enterprise IT and healthcare services by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Digital, Enterprise IT and Healthcare Services
Digital, enterprise IT and healthcare services reward patient research into demand, execution and financial strength. Mphasis, HCL Technologies and Inventurus Knowledge Solutions each have a clear plan to grow. Based on the 28 October 2026 close, Mphasis trades at Rs 2,518, HCL Technologies at Rs 1,400.5 and Inventurus Knowledge Solutions at Rs 1,692.8.
Download the Univest iOS App or Univest Android App to track digital, enterprise IT and healthcare services, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are digital, enterprise IT and healthcare services?
Ans. Digital, enterprise IT and healthcare services are listed technology companies that build applications, cloud and modernisation projects for banks and insurers, deliver software, infrastructure and engineering services and support United States healthcare providers with revenue cycle and technology services. Their earnings depend on client budgets, deal wins and currency. This list looks at three of them, Mphasis, HCL Technologies and Inventurus Knowledge Solutions, using reported FY22 to FY26 financials and the 28 October 2026 closing prices.
Which digital, enterprise IT and healthcare services are covered in this list?
Ans. This list covers Mphasis, HCL Technologies and Inventurus Knowledge Solutions. Based on the 28 October 2026 close, Mphasis traded at Rs 2,518, HCL Technologies at Rs 1,400.5 and Inventurus Knowledge Solutions at Rs 1,692.8. Their return on equity ranges from 17.3% to 25.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.5% to 42.2%.
Why do digital, enterprise IT and healthcare services have a strong future roadmap in India?
Ans. Digital, enterprise IT and healthcare services have a strong roadmap in India because steady global spending on digital transformation, cloud and data work and rising outsourcing in healthcare keep widening the market for Indian technology and services firms. The main drivers are as follows. Cloud projects. Banks and insurers modernise core systems. Infrastructure work. Large clients outsource technology operations. Healthcare services. Providers outsource billing and technology tasks. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Mphasis performed financially?
Ans. Revenue rose from Rs 12,122 crore in FY22 to Rs 16,206 crore in FY26, a compound annual growth rate of 7.5%. Net profit grew from Rs 1,431 crore in FY22 to Rs 1,863 crore in FY26, which works out to a compound annual growth rate of 6.8%. In the June 2026 quarter, revenue grew 17.1% year on year to Rs 4,467 crore, while net profit rose 10.8% to Rs 490 crore. The company has a return on equity of 17.3%, a debt to equity ratio of 0.24 and a market capitalisation of Rs 47,695 crore. The stock trades at a P/E of 25.0, above the industry P/E of 17.5. Looking ahead, the company has stressed an AI-led approach and strengthened its sales relationships with large clients. A broad client base in financial services provides recurring revenue, and its investments in cloud and data skills support growth.
How has HCL Technologies performed financially?
Ans. Revenue rose from Rs 86,718 crore in FY22 to Rs 131,674 crore in FY26, a compound annual growth rate of 11.0%. Net profit grew from Rs 13,523 crore in FY22 to Rs 16,652 crore in FY26, which works out to a compound annual growth rate of 5.3%. The company has a return on equity of 24.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 384,255 crore. The stock trades at a P/E of 21.0, above the industry P/E of 17.6. Looking ahead, the company is building its business around cloud, data and artificial intelligence services and large multi-year deals with global clients. Its engineering services and software product lines add recurring revenue alongside core IT services.
How has Inventurus Knowledge Solutions performed financially?
Ans. Revenue rose from Rs 784 crore in FY22 to Rs 3,211 crore in FY26, a compound annual growth rate of 42.2%. Net profit grew from Rs 233 crore in FY22 to Rs 722 crore in FY26, which works out to a compound annual growth rate of 32.7%. In the June 2026 quarter, revenue grew 21.0% year on year to Rs 899 crore, while net profit rose 27.8% to Rs 194 crore. The company has a return on equity of 25.8%, a debt to equity ratio of 0.27 and a market capitalisation of Rs 29,242 crore. The stock trades at a P/E of 38.3, above the industry P/E of 17.6. Looking ahead, the company is widening its technology-led services for risk adjustment, care coordination and revenue cycle work. Long-term relationships with large healthcare organisations give it recurring demand.
What risks should investors check before buying digital, enterprise IT and healthcare services?
Ans. Investors should check a few risks before buying digital, enterprise IT and healthcare services. Deal timing. Large contracts can shift between periods. Client budgets. Spending can vary with global conditions. Currency moves. Export earnings move with the rupee. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of digital, enterprise IT and healthcare services investment advice?
Ans. No. This article is educational and uses publicly available data as of the 28 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
Recent Articles

3 Wind Turbine Maker, Largest Power Generator and Leading Wires and Cables Producer Stocks With a Strong Future Roadmap: Suzlon Energy, NTPC and Polycab India
29 October 2026

3 Premium Residential and Commercial Developer, Largest Tile Maker and Northern Cement Producer Stocks With a Strong Future Roadmap: Oberoi Realty, Kajaria Ceramics and JK Lakshmi Cement
29 October 2026

3 Utility Vehicle and Tractor Leader, Diversified Agribusiness and Crop Protection Company Stocks With a Strong Future Roadmap: Mahindra and Mahindra, Godrej Agrovet and Insecticides India
29 October 2026

3 Active Ingredients and Custom Manufacturing Specialist, Paracetamol and Formulations Leader and Crop Science Innovator Stocks With a Strong Future Roadmap: Neuland Laboratories, Granules India and PI Industries
29 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
3 Wind Turbine Maker, Largest Power Generator and Leading Wires and Cables Producer Stocks With a Strong Future Roadmap: Suzlon Energy, NTPC and Polycab India
3 Premium Residential and Commercial Developer, Largest Tile Maker and Northern Cement Producer Stocks With a Strong Future Roadmap: Oberoi Realty, Kajaria Ceramics and JK Lakshmi Cement
3 Utility Vehicle and Tractor Leader, Diversified Agribusiness and Crop Protection Company Stocks With a Strong Future Roadmap: Mahindra and Mahindra, Godrej Agrovet and Insecticides India
3 Active Ingredients and Custom Manufacturing Specialist, Paracetamol and Formulations Leader and Crop Science Innovator Stocks With a Strong Future Roadmap: Neuland Laboratories, Granules India and PI Industries
3 Tractor and Construction Equipment Company, Regional Dairy Processor and Phosphatic Fertiliser Producer Stocks With a Strong Future Roadmap: Escorts Kubota, Dodla Dairy and Paradeep Phosphates

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





